GALECTIN THERAPEUTICS INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
GALECTIN THERAPEUTICS INC. (GALT) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-29.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-03-29
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $0.00.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was $0.00.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was $0.00.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-03-31 was $0.00.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was $0.00.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $0.00.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was $0.00.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$400.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-29 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $0.00 derived: sum of 2 quarters · filed 2018-03-29 | $0.00 derived: sum of 3 quarters · filed 2018-03-29 | $0.00 10-K · filed 2018-03-29 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $0.00 derived: sum of 2 quarters · filed 2016-11-08 | $0.00 10-Q · filed 2016-11-08 | $0.00 derived: sum of 4 quarters · filed 2017-03-28 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 | $0.00 derived: sum of 3 quarters · filed 2017-03-28 | $0.00 derived: sum of 4 quarters · filed 2017-03-28 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-10 | $0.00 derived: sum of 2 quarters · filed 2017-03-28 | $0.00 derived: sum of 3 quarters · filed 2017-03-28 | $0.00 derived: sum of 4 quarters · filed 2017-03-28 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-28 | $0.00 derived: sum of 2 quarters · filed 2017-03-28 | $0.00 derived: sum of 3 quarters · filed 2017-03-28 | $0.00 10-K · filed 2017-03-28 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $0.00 derived: sum of 2 quarters · filed 2016-11-08 | $0.00 10-Q · filed 2016-11-08 | $0.00 derived: sum of 4 quarters · filed 2016-11-08 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 | $0.00 derived: sum of 3 quarters · filed 2016-08-09 | $0.00 derived: sum of 4 quarters · filed 2016-08-09 |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-10 | $0.00 derived: sum of 2 quarters · filed 2016-05-10 | $0.00 derived: sum of 3 quarters · filed 2016-05-10 | $0.00 derived: sum of 4 quarters · filed 2016-05-10 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | $0.00 derived: sum of 3 quarters · filed 2016-03-15 | -$400.00K 10-K · filed 2016-03-15 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | -$400.00K 10-Q · filed 2015-11-09 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$400.00K 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | -$400.00K 10-Q · filed 2015-05-11 | |||
| 2012-12-31 | $64.00K 10-K · filed 2015-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |